Lanton Law

Lanton Law Blog

Learn about the latest trends and activities through our blog posts.

Posts tagged direct and indirect remuneration fees
New Proposed Congressional DIR Relief Bill
New Proposed Congressional DIR Relief Bill

At Lanton Law we are constantly on the watch for issues impacting our specialty, retail and LTC pharmacy clients including the issue of DIR fees. Clients utilize our advocacy and legal tools while discussing business strategy to combat an ever changing reimbursement environment.

Read More
pharmacy, pharmacy benefit manager, pharmaceuticals, specialty pharmacy, LTC, life sciences, Long term care pharmacy, insurance, healthcareRon LantonPharmacy DIR Reform to Reduce Senior Drug Costs Act, DIR, Pharmacy, PBM, direct and indirect remuneration fees
NCPA Files Lawsuit on Pharmacy Direct & Indirect Remuneration (DIR) Fees
NCPA Files Lawsuit on Pharmacy Direct & Indirect Remuneration (DIR) Fees

The National Community Pharmacists Association (NCPA) has filed a lawsuit against the U.S. Department of Health & Human Services (HHS) on DIR fees. Specifically, the complaint seeking declaratory and injunctive relief seeks three things according to NCPA’s release:

Read More
pharmacy, pharmaceuticals, pharmacy benefit manager, Medicare, Medicare Part D, lawsuits, healthcare, insurance, HHSRon LantonPharmacy, U.S. Department of Health &  Human Services, DIR fee, direct and indirect remuneration fees, HHS, federal court, law, lawsuit
Pharmacy Times Interviews Lanton Law On How COVID-19 May Lead to the Expansion of Practice Laws for Pharmacists Across the Country
Pharmacy Times Interviews Lanton Law On How COVID-19 May Lead to the Expansion of Practice Laws for Pharmacists Across the Country

Alana Hippensteele; Editor, MA of Pharmacy Times interviewed Ron Lanton to discuss how COVID-19 may lead to expansion of practice laws for pharmacists across the country.

Read More
Congress, government affairs, healthcare, Medicare Part B, pharmaceuticals, pharmacy, CMSRon LantonCOVID-19, pharmacy, pharmacy provider status, scope of practice, Congress, legislature, advocacy, regulatory, DIR, direct and indirect remuneration fees, personal protective equipment, PPE, CLIA Waiver
Lanton Law Interviews the Massachusetts Pharmacists Association on DIR & Provider Status
Lanton Law Interviews the Massachusetts Pharmacists Association on DIR & Provider Status

We are excited to have Lindsay De Santis; Executive Vice President of the Massachusetts Pharmacists Association (MPhA) do a blogcast with us. Our conversation covers pharmacy DIR (direct and indirect remuneration) fees, pharmacy provider status and COVID-19.

Read More
life sciences, pharmaceuticals, pharmacy, reimbursement, Medicare Part B, Medicare Part DRon LantonDIR fee, DIR, direct and indirect remuneration fees, pharmacy provider status, provider status, COVID-19, Massachusetts, Massachusetts Pharmacists Association